• J&J denies the allegations, saying decades of scientific testing and regulatory approvals have shown its talc to be safe and asbestos-free.

• It reiterated the statement as it announced the discontinuation of the product.

Johnson & Johnson
Johnson & Johnson Johnson & Johnson

 Johnson & Johnson will no longer be selling its Talcum powder worldwide from 2023.

This follows 38,000 lawsuits to get Johnson & Johnson to stop selling its talcum powder, which is accused of asbestos contamination linked to cancer.

The powder is widely used by Kenyan mothers to prevent nappy rash.

“...we have made the commercial decision to transition to an all cornstarch-based baby powder...As a result of this transition, talc-based...powder will be discontinued globally in 2023.” read a statement.

The drugmaker said on Thursday (Aug 11), more than two years after it ended US sales of a product that drew thousands of consumer safety lawsuits.

"As part of a worldwide portfolio assessment, we have made the commercial decision to transition to an all cornstarch-based baby powder portfolio," it said, adding that cornstarch-based baby powder is already sold in countries around the world.

In 2020, J&J announced that it would stop selling its talc Baby Powder in the United States and Canada because demand had fallen in the wake of what it called "misinformation" about the product's safety amid a barrage of legal challenges.

WATCH: For the latest videos on entertainment stories

Check out the latest news here and you are welcome to join our super exclusive Mpasho Telegram group for all the latest and breaking news in entertainment. We would also like to hear from you, WhatsApp us on +254 736 944935.